Search

Limb-girdle muscular dystrophy (LGMD)
Community Letter: SRP-9001 Advisory Committee Date is Announced
Sarepta Therapeutics Announces that the Date of the Advisory Committee Meeting for SRP-9001 will be May 12, 2023
Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pride proud: What belonging feels like and why representation matters
A conversation with CFO Ian Estepan, recipient of the 2022 CFO of the Year award from the Boston Business Journal
Ensuring the safety of clinical trial participants: Meet Eddie Darton, M.D.
Measurements used in clinical trials for Duchenne muscular dystrophy – an overview